stars 1 stars 2 stars 3

Zarbio is focused on discovering pathophysiology-based treatments for neurodegeneration. We created an experimental platform to study cellular membrane damage induced by misfolding proteins, such as beta-amyloid, which is a prime suspect in Alzheimer's disease. Our research has allowed us to advance the membrane channel theory of neurodegeneration and find new pharmacological targets for treatment.

Employees 1 (1 on RocketReach)
Founded 2018
Industry Research Services

Zarbio Questions

Dmitry Zaretsky is the Founder, Principal Scientist of Zarbio.

1 people are employed at Zarbio.

Top Zarbio Employees

View Similar People
G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users